146 related articles for article (PubMed ID: 16556634)
1. Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA.
Green MD; Beall B; Marcon MJ; Allen CH; Bradley JS; Dashefsky B; Gilsdorf JR; Schutze GE; Smith C; Walter EB; Martin JM; Edwards KM; Barbadora KA; Wald ER
J Antimicrob Chemother; 2006 Jun; 57(6):1240-3. PubMed ID: 16556634
[TBL] [Abstract][Full Text] [Related]
2. Community-based surveillance in the united states of macrolide-resistant pediatric pharyngeal group A streptococci during 3 respiratory disease seasons.
Tanz RR; Shulman ST; Shortridge VD; Kabat W; Kabat K; Cederlund E; Rippe J; Beyer J; Doktor S; Beall BW;
Clin Infect Dis; 2004 Dec; 39(12):1794-801. PubMed ID: 15578402
[TBL] [Abstract][Full Text] [Related]
3. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002.
Szczypa K; Sadowy E; Izdebski R; Hryniewicz W
J Antimicrob Chemother; 2004 Oct; 54(4):828-31. PubMed ID: 15329367
[TBL] [Abstract][Full Text] [Related]
4. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
Farrell DJ; Jenkins SG
J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
Gattringer R; Sauermann R; Lagler H; Stich K; Buxbaum A; Graninger W; Georgopoulos A
Int J Antimicrob Agents; 2004 Sep; 24(3):290-3. PubMed ID: 15325435
[TBL] [Abstract][Full Text] [Related]
6. [Macrolide resistance phenotypes and genotypes in group G streptococci].
Açikgöz ZC; Göçer S; Almayanlar E
Mikrobiyol Bul; 2003; 37(2-3):117-24. PubMed ID: 14593892
[TBL] [Abstract][Full Text] [Related]
7. Emergence of macrolide-resistant Streptococcus pyogenes strains in French children.
Bingen E; Bidet P; Mihaila-Amrouche L; Doit C; Forcet S; Brahimi N; Bouvet A; Cohen R
Antimicrob Agents Chemother; 2004 Sep; 48(9):3559-62. PubMed ID: 15328126
[TBL] [Abstract][Full Text] [Related]
8. Macrolide resistance determinants of group A streptococci in Ankara, Turkey.
Acikgoz ZC; Gocer S; Tuncer S
J Antimicrob Chemother; 2003 Jul; 52(1):110-2. PubMed ID: 12805256
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterisation of Hungarian macrolide-resistant Streptococcus pneumoniae isolates, including three highly resistant strains with the mef gene.
Dobay O; Rozgonyi F; Amyes SG
Int J Antimicrob Agents; 2005 Jun; 25(6):488-95. PubMed ID: 15878263
[TBL] [Abstract][Full Text] [Related]
10. Reemergence of macrolide resistance in pharyngeal isolates of group a streptococci in southwestern Pennsylvania.
Green M; Martin JM; Barbadora KA; Beall B; Wald ER
Antimicrob Agents Chemother; 2004 Feb; 48(2):473-6. PubMed ID: 14742197
[TBL] [Abstract][Full Text] [Related]
11. [Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002].
Senses Z; Baysallar M; Gür D; Doğanci L
Mikrobiyol Bul; 2003 Oct; 37(4):225-34. PubMed ID: 14748258
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.
Uh Y; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
Antimicrob Agents Chemother; 2004 Jul; 48(7):2716-8. PubMed ID: 15215133
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and molecular characterization of macrolide and streptogramin resistance in Streptococcus mitis from neutropenic patients.
Achour W; Guenni O; Malbruny B; Canu A; Leclercq R; Hassen AB
J Antimicrob Chemother; 2004 Jul; 54(1):117-21. PubMed ID: 15190021
[TBL] [Abstract][Full Text] [Related]
14. Distribution of subclasses mefA and mefE of the mefA gene among clinical isolates of macrolide-resistant (M-phenotype) Streptococcus pneumoniae, viridans group streptococci, and Streptococcus pyogenes.
Ardanuy C; Tubau F; Liñares J; Domínguez MA; Pallarés R; Martín R;
Antimicrob Agents Chemother; 2005 Feb; 49(2):827-9. PubMed ID: 15673780
[TBL] [Abstract][Full Text] [Related]
15. [Study of macrolide-resistant genes in group C and G streptococci].
Seral C; González V; Castillo J; García C; Rubio MC; Gómez-Lus R
Rev Esp Quimioter; 2000 Jun; 13(2):171-5. PubMed ID: 10918090
[TBL] [Abstract][Full Text] [Related]
16. Erythromycin-resistant group A streptococci.
Shulman ST; Tanz R; Kabat W
N Engl J Med; 2002 Aug; 347(8):614-5; author reply 614-5. PubMed ID: 12195586
[No Abstract] [Full Text] [Related]
17. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile.
Palavecino EL; Riedel I; Berrios X; Bajaksouzian S; Johnson D; Kaplan E; Jacobs MR
Antimicrob Agents Chemother; 2001 Jan; 45(1):339-41. PubMed ID: 11120993
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States.
Green M; Allen C; Bradley J; Dashefsky B; Gilsdorf JR; Marcon MJ; Schutze GE; Smith C; Walter E; Martin JM; Edwards KA; Barbadora KA; Rumbaugh RM; Wald ER
Antimicrob Agents Chemother; 2005 Jun; 49(6):2487-9. PubMed ID: 15917551
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany.
Schoening TE; Wagner J; Arvand M
Clin Microbiol Infect; 2005 Jul; 11(7):579-82. PubMed ID: 15966978
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections.
Ikebe T; Hirasawa K; Suzuki R; Isobe J; Tanaka D; Katsukawa C; Kawahara R; Tomita M; Ogata K; Endoh M; Okuno R; Watanabe H
Antimicrob Agents Chemother; 2005 Feb; 49(2):788-90. PubMed ID: 15673769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]